Nektar Therapeutics Corporation
Nektar Therapeutics develops therapeutics based on its advanced polymer conjugate chemistry technology platform.
Estimated Revenue:
$50M to $100M
Funding Status:
IPO
Industry:
Pharma
Acquisitions Number:
2.0
Number Of Exists:
1
Technology:
Biotechnology, Chemical, Health Care, Therapeutics
Founded Date:
1990
Headquarters:
San Carlos, California, United States
Total Funding:
1200000000
Last Funding Type:
Post-IPO Equity
Employee Number:
501-1000